OptimizeRx (OPRX) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-0.03 and quarterly revenue of $18.39M.

In the most recent quarter (Q4), OptimizeRx reported EPS of $0.51, beating estimates of $0.18 by 1.83%. Revenue came in at $32.24M, exceeding the estimate of $31.18M by 0.03%.

OptimizeRx has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, OptimizeRx has averaged an EPS surprise of 8.38% and a revenue surprise of 0.15%.